NDC product
Bebtelovimab
NDC 0002-7589 · Eli Lilly and Company
Key facts
| Product NDC | 0002-7589 |
|---|---|
| Proprietary name | Bebtelovimab |
| Labeler | Eli Lilly and Company |
| Marketing category | EMERGENCY USE AUTHORIZATION |
| Marketing start | Feb 11, 2022 |
| Marketing end | Dec 13, 2024 |
| Listing certified through | Dec 13, 2024 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: